A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder-Reference-Cited by-同舟云学术

A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder

Published:2021-03-08 Issue:5 Volume:37 Page:867-877
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Phiri Kelesitse¹,Hallas Jesper²,Linder Marie³,Margulis Andrea⁴,Suehs Brandon⁵,Arana Alejandro⁴,Bahmanyar Shahram³,Hoffman Veena¹,Enger Cheryl¹,Horter Libby⁵,Odsbu Ingvild³,Olesen Morten²,Perez-Gutthann Susana⁴,Kristiansen Nina Sahlertz²,Appenteng Kwame⁶,de Vogel Stefan⁷,Seeger John¹

Affiliation:

1. Optum Epidemiology, Boston, MA, USA

2. Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark

3. Centre for Pharmacoepidemiology, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

4. Epidemiology, RTI Health Solutions, Barcelona, Spain

5. Humana Healthcare Research, Humana, Louisville, KY, USA

6. Pharmacovigilance, Astellas Pharma US, Chicago, IL, USA

7. Pharmacovigilance, Astellas Pharma Europe B.V, Leiden, The Netherlands

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1891035

Reference31 articles.

1. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society

2. An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction

3. Rahnama’i S. Overactive bladder. Current Definition. 2018. [cited 2021 Jan 14]. Available from: https://www.ics.org/committees/standardisation/terminologydiscussions/overactivebladder.

4. Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program;Pharmacoepidemiology and Drug Safety;2024-04-29

2. Published registry-based pharmacoepidemiologic associations show limited concordance with agnostic medication-wide analyses;Journal of Clinical Epidemiology;2023-08

3. Identification of Drug–Cancer Associations: A Nationwide Screening Study;Cancer Research Communications;2022-06-29

4. Clinical Utility of β3-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations;Research and Reports in Urology;2022-04